Atlas Trials

A Phase II Study of T-DXd Plus SRT in HER2-positive Breast Cancer Brain Metastases

Clinical trial NCT06088056 · UNKNOWN

Trial details

NCT number
NCT06088056
Sponsor
Fudan University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Breast CancerBrain MetastasesRadiotherapy
Start date
2023-11-01
Primary completion
2024-06-01
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.